
Algorithm tracks cancer type down to methylation pattern
The group headed by Stefan Pfister at German Cancer Research Center (Heidelberg) reported in Nature that the availability of their method...

European biotech stocks: 2017 with strong results
Following the more cautious year 2016, the European biotech sector witnessed a significant volume increase in IPOs and follow-on financings in 2017....

Pieris inks US$1.2bn immuno-oncology deal with Seattle Genetics
The partnership aims at combining Pieris’ anticalin platform with Seattle Genetics’ monoclonal antibodies portfolio to treat solid tumours and...

Sanofi acquiring Ablynx
Sanofi offered to acquire all outstanding ordinary shares, including Ablynx’ American Depositary Shares (ADSs), warrants and convertible bonds at a...

Germany to boost the bioeconomy
One month before the Summit, the Bioeconomy Council warned that Germany could lose its leading role in the bioeconomy. According to a country study...

Canopy acquires Czech Annabis Medical sro
Unter the terms of the agreement, Canopy will pay approximately CAN-$2.5m (€1.6m). Particularly, the company will issue 50,735 common shares valued...

Convert Pharmaceuticals SA closes €13.6m Series A round
The proceeds will be used to prepare and conduct Phase I clinical studies with Convert's nitroaromatic lead anti-cancer drug CP-506, which may bring...